Albireo Pharma, Inc.

Home » Albireo Pharma, Inc.

Secondary

Albireo Pharma, Inc.

Albireo Pharma is a clinical-stage biopharmaceutical company focused through its operating subsidiary on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders.

Symbol

ALBO

Last Closing Price
$35.76

Shares
1,400,000

Effective Date
January 25, 2018

Underwriters
Cowen & Co., William Blair

To view the prospectus for Albireo Pharma, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253